Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 114901-114950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03252717
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)
NAActive, not recruiting
500 participants
Started: Aug 31, 2014
1 condition1 sponsor1 location
NCT02269592
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
N/ARecruiting
10,000 participants
Started: Aug 31, 2014 · Completed: Sep 30, 2030
9 conditions2 sponsors7 locations
NCT02851043
Non-Invasive Respiratory Monitor
NARecruiting
20 participants
Started: Aug 31, 2014 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT01842724
Motec Versus Remotion Total Wrist Arthroplasty - A Prospective Study
NAActive, not recruiting
40 participants
Started: Aug 31, 2014 · Completed: Nov 30, 2034
1 condition1 sponsor1 location
NCT02803242
COPD Patient-Powered Research Network
N/ARecruiting
75,000 participants
Started: Aug 31, 2014 · Completed: Jan 31, 2030
4 conditions2 sponsors1 location
NCT02130362
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
N/AActive, not recruiting
1,446 participants
Started: Aug 28, 2014 · Completed: Nov 30, 2030
1 condition1 sponsor148 locations
NCT02100722
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
NAActive, not recruiting
1,500 participants
Started: Aug 25, 2014 · Completed: Apr 30, 2025
2 conditions10 sponsors46 locations
NCT02157324
Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia
PHASE1Active, not recruiting
12 participants
Started: Aug 18, 2014 · Completed: Apr 1, 2026
1 condition1 sponsor3 locations
NCT06704451
Perioperative IL-33 is Associated with the Early Stage of Postoperative Neurocognitive Dysfunction After Major Abdominal Surgery
N/ARecruiting
150 participants
Started: Aug 18, 2014 · Completed: Dec 30, 2025
4 conditions1 sponsor1 location
NCT02378259
Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity
NAActive, not recruiting
50 participants
Started: Aug 15, 2014 · Completed: Jun 30, 2034
5 conditions4 sponsors3 locations
NCT02203526
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
PHASE1Recruiting
93 participants
Started: Aug 14, 2014 · Completed: Jun 15, 2027
1 condition1 sponsor1 location
NCT02152995
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
PHASE2Active, not recruiting
34 participants
Started: Aug 14, 2014 · Completed: Jan 25, 2026
12 conditions1 sponsor1 location
NCT02159755
Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma
PHASE1Active, not recruiting
28 participants
Started: Aug 13, 2014 · Completed: Jun 6, 2026
1 condition1 sponsor4 locations
NCT02208388
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial
NARecruiting
1,000 participants
Started: Aug 12, 2014 · Completed: Mar 5, 2028
1 condition1 sponsor7 locations
NCT02176967
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
PHASE3Active, not recruiting
621 participants
Started: Aug 8, 2014 · Completed: Sep 30, 2026
4 conditions2 sponsors222 locations
NCT03452878
Evaluation of the Functional Results of Bilateral Amygdalotomy for Refractory Aggressive Patients
N/AActive, not recruiting
4 participants
Started: Aug 6, 2014 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT02143466
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
PHASE1Active, not recruiting
344 participants
Started: Aug 5, 2014 · Completed: Dec 31, 2025
1 condition1 sponsor42 locations
NCT02077894
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions
N/ARecruiting
1,685 participants
Started: Aug 5, 2014 · Completed: Aug 5, 2029
1 condition1 sponsor1 location
NCT03623100
Neural Indices of Intervention Outcomes in Children With Speech Sound Disorders
NAActive, not recruiting
42 participants
Started: Aug 1, 2014 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT04198337
Endoscopic Full Thickness Resection for Gastric GIST
NARecruiting
30 participants
Started: Aug 1, 2014 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT02401685
POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer
NAActive, not recruiting
1,900 participants
Started: Aug 1, 2014 · Completed: Dec 31, 2026
1 condition5 sponsors50 locations
NCT02178163
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NARecruiting
1,020 participants
Started: Aug 1, 2014 · Completed: Jul 31, 2027
2 conditions2 sponsors11 locations
NCT03395509
The Intersectional Viborg Screening Program: Cost-(Effectiveness) of Screening for Diabetes and Cardiovascular Diseases
N/AEnrolling by invitation
4,500 participants
Started: Aug 1, 2014 · Completed: Aug 1, 2029
8 conditions2 sponsors1 location
NCT06128317
Myocardial Infarction Registry
N/ARecruiting
2,500 participants
Started: Aug 1, 2014 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT02255383
Persona Total Knee Arthroplasty Outcomes Study
NAActive, not recruiting
737 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2027
7 conditions1 sponsor14 locations
NCT02865330
Spanish Urological Association Registry of Patients on Active Surveillance
N/ARecruiting
946 participants
Started: Jul 31, 2014 · Completed: Jul 31, 2034
1 condition1 sponsor1 location
NCT02236910
An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients with Somatostatin Receptor Positive Tumours
PHASE2Active, not recruiting
66 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02199054
Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome
NAActive, not recruiting
20 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT02155621
Personalized Oncogenomics (POG) Program of British Columbia
NARecruiting
5,000 participants
Started: Jul 31, 2014 · Completed: Mar 31, 2026
3 conditions2 sponsors1 location
NCT02246140
Intracranial Arterial Stenosis and Resin of Cannabis Use
NARecruiting
60 participants
Started: Jul 31, 2014 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT02266745
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
PHASE2Active, not recruiting
109 participants
Started: Jul 31, 2014 · Completed: Apr 1, 2025
9 conditions1 sponsor25 locations
NCT02192619
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
N/ARecruiting
500 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT02194647
Anti-osteoporosis Medication Monitoring and Management Service
N/AActive, not recruiting
500 participants
Started: Jul 31, 2014 · Completed: Jul 1, 2026
2 conditions1 sponsor1 location
NCT02908048
Extracellular RNA Markers of Liver Disease and Cancer
N/AActive, not recruiting
1,810 participants
Started: Jul 31, 2014 · Completed: Jul 31, 2026
4 conditions1 sponsor4 locations
NCT02399124
Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma
NAActive, not recruiting
120 participants
Started: Jul 31, 2014 · Completed: Feb 28, 2026
1 condition3 sponsors2 locations
NCT02446431
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
EARLY_PHASE1Recruiting
20 participants
Started: Jul 31, 2014 · Completed: Jul 31, 2029
1 condition2 sponsors2 locations
NCT02223923
Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid Tumours
PHASE1Active, not recruiting
87 participants
Started: Jul 31, 2014 · Completed: Dec 30, 2025
1 condition4 sponsors3 locations
NCT02920554
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer
NARecruiting
88 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT02154022
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
N/AEnrolling by invitation
100 participants
Started: Jul 31, 2014 · Completed: May 1, 2030
3 conditions1 sponsor1 location
NCT03275311
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
N/ARecruiting
40,000 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2026
1 condition11 sponsors20 locations
NCT02425774
Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway
PHASE4Recruiting
30 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02196376
Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome
N/AActive, not recruiting
212 participants
Started: Jul 31, 2014 · Completed: Jul 31, 2029
1 condition1 sponsor1 location
NCT02207465
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer
PHASE1Recruiting
42 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT02191488
ALA-induced PpIX Fluorescence During Brain Tumor Resection
PHASE1Active, not recruiting
540 participants
Started: Jul 31, 2014 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT02276430
TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects
N/AActive, not recruiting
939 participants
Started: Jul 31, 2014 · Completed: Apr 30, 2026
1 condition2 sponsors3 locations
NCT01503086
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
NAActive, not recruiting
45 participants
Started: Jul 30, 2014 · Completed: Dec 31, 2025
2 conditions2 sponsors28 locations
NCT02215928
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
N/ARecruiting
100 participants
Started: Jul 28, 2014 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02107703
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
PHASE3Active, not recruiting
669 participants
Started: Jul 22, 2014 · Completed: Dec 31, 2027
1 condition1 sponsor146 locations
NCT02138734
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
596 participants
Started: Jul 21, 2014 · Completed: Dec 31, 2038
1 condition1 sponsor80 locations
NCT02101775
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE2Active, not recruiting
124 participants
Started: Jul 21, 2014 · Completed: Feb 20, 2026
12 conditions1 sponsor16 locations